President & CEO, Aeolian Biotech
Dr. Martin is a Nebraska native with more than 20 years of experience in the biotechnology industry. He has led development activities to support more than 100 Investigational New Drug (IND) Applications, and developed four drugs that eventually received FDA or EMA approval. He has held senior leadership positions in a number of biotech companies including Chiron (purchased by Novartis for $8.6B), Sangamo (current market cap, $500M) and most recently Dynavax (current market cap, $900M).
He is also the Chairman and CEO of Great Plains Biotechnology, a consulting company with headquarters in Lincoln. Great Plains was founded in Nebraska to enable capital efficient operations and exploit Dr. Martin’s life science leadership expertise and professional network. He is also Chairman and CEO of Hudson Biotechnology, a private vaccine company based in Lincoln that aspires to develop a vaccine against Lyme Disease. He serves as Chairman of the Board for UNIVAC Technologies, a private vaccine company based in Brussels, Belgium. He serves on the boards of the European Union Society of Translational Medicine, the Vaccine Policy Advisory Board of BIO, the Biodefense Policy Advisory Board of BIO, EPSCor, BioNebraska, and Redeemer Seminary.
Dr. Martin received a bachelor’s degree with honors from the University of Nebraska at Kearney, and an MD degree from the University of Nebraska College of Medicine, where he was named the outstanding student in Pediatrics. He was a resident in Pediatrics at the University of Nebraska Medical Center and was a post-doctoral fellow in Molecular Microbiology and Pediatric Infectious Diseases at Washington University in St. Louis where he was named the outstanding teaching fellow at St. Louis Children’s Hospital.
Related posts:
Virtual ‘Women in STEM’ event is Aug. 11
Bio Nebraska will host a free virtual presentation next month, “Nebraska women in STEM: Finding what you need to succeed (or creating it if it doesn’t exist).” The event is planned for Tuesday, Aug. 11, at 10:30-11:30 a.m. Lisa Bilek, Ph.D., will tell the story of how she built and developed a stable career in …
UNMC, UNO form new institute to help start-ups succeed
UNeTech facility at 3929 Harney St. will provide affordable space in 3-level, 5,000-sq.-ft. building by Vicky Cerino, UNMC The University of Nebraska Medical Center and the University of Nebraska at Omaha are partnering on a new institute designed to identify promising start-up companies and help them become successful. The institute – called UNeTech – will …
UNeMed highlights success in 2016 Shareholder Meeting
by Charles Litton, UNeMed OMAHA, Neb. (Aug. 18, 2016)—UNeMed Corporation, the technology transfer and commercialization office for the University of Nebraska Medical Center, concluded another successful fiscal year with its annual shareholder meeting at TD Ameritrade Park’s Skybox Lounge. The meeting brought together key UNMC leadership and researchers who mixed and mingled while learning about …
Tyler Martin joins UNeMed board of directors
OMAHA, Neb. (Aug. 5, 2014)—UNeMed Corporation announced at its annual shareholder meeting that Tyler Martin, M.D., has been added to the board of directors. Martin, a product of Hebron, Neb., joins UNeMed after a long stretch of success in Silicon Valley where he helped build new startups and managed established biotech companies. His experience in …
